Study of liver cirrhosis over ten consecutive years in Southern China

Table 6 Complications in the 8080 liver cirrhosis patients by gender n (%)

Complication	Total(n = 8080)	Male(n = 6719)	Female(n = 1361)	χ2value	P value
UGIB	1006 (12.5)	875 (13.0)	131 (9.6)	12.00	0.001
Infection	2177 (26.9)	1806 (26.9)	371 (27.3)	0.08	0.773
Ascites	4493 (55.6)	3739 (55.6)	754 (55.4)	0.03	0.867
HCC	2399 (29.7)	2157 (32.1)	242 (17.8)	111.21	< 0.001
HE	544 (6.7)	464 (6.9)	80 (5.9)	1.90	0.168
PVT	405 (5.0)	342 (5.1)	63 (4.6)	0.51	0.477
PVTT	783 (9.7)	733 (10.9)	50 (3.7)	67.7	< 0.001
CTPV	250 (3.1)	229 (3.4)	21 (1.5)	13.13	< 0.001
HRS	293 (3.6)	252 (3.8)	41 (3.0)	1.76	0.184
HPS	6 (0.1)	4 (0.1)	2 (0.1)	1.17	0.280
HHT	398 (4.9)	337 (5.0)	61 (4.5)	0.69	0.407

Because some patients have more than one complication, number is greater than 8080; The P values were determined using the χ² test. UGIB: Upper gastrointestinal bleeding; HCC: Hepatocellular carcinoma; HE: Hepatic encephalopathy; PVT: Portal vein thrombosis; PVTT: Portal vein tumor thrombosis; CTPV: Cavernous transformation of the portal vein; HRS: Hepatorenal syndrome; HPS: Hepatopulmonary syndrome; HHT: Hepatic hydrothorax.